These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 23789291)

  • 1. Preparation for radioiodine therapy: how to increase therapeutic efficacy and accelerate unbound radioiodine excretion.
    Matović M
    Vojnosanit Pregl; 2013 May; 70(5):504-10. PubMed ID: 23789291
    [No Abstract]   [Full Text] [Related]  

  • 2. Diagnostic 123I and 131I activities and radioiodine therapy. Effects on urinary iodine excretion in patients with differentiated thyroid carcinoma.
    Meller B; von Hof K; Genina E; Deisting W; Meller J; Richter E; Baehre M
    Nuklearmedizin; 2005; 44(6):243-8. PubMed ID: 16400384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroglobulin-positive, radioiodine-negative thyroid cancer.
    Levy EG
    Thyroid; 2001 Jun; 11(6):599-602. PubMed ID: 11442009
    [No Abstract]   [Full Text] [Related]  

  • 4. Thyroid suppression and radioiodine treatment for differentiated thyroid cancer.
    Rösler H
    Arch Otolaryngol Head Neck Surg; 1987 Jul; 113(7):778-9. PubMed ID: 3580165
    [No Abstract]   [Full Text] [Related]  

  • 5. Unexpected effect of furosemide on radioiodine urinary excretion in patients with differentiated thyroid carcinomas treated with iodine 131.
    Matovic MD; Jankovic SM; Jeremic M; Tasic Z; Vlajkovic M
    Thyroid; 2009 Aug; 19(8):843-8. PubMed ID: 19519221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Age of menopause in patients with differentiated thyroid cancer treated with radioiodine].
    Manuel García-Quirós Muñoz J; Martín Hernández T; Torres Cuadro A; Cambil Molina T; Castro Montaño J; Sendón Pérez A
    Endocrinol Nutr; 2010 Mar; 57(3):105-9. PubMed ID: 20304710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. rhTSH-aided radioiodine ablation and treatment of differentiated thyroid carcinoma: a comprehensive review.
    Luster M; Lippi F; Jarzab B; Perros P; Lassmann M; Reiners C; Pacini F
    Endocr Relat Cancer; 2005 Mar; 12(1):49-64. PubMed ID: 15788638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A potential false-positive posttherapy radioiodine scan secondary to I-131 excretion in perspiration.
    Joyce WT; Cowan RJ
    Clin Nucl Med; 1995 Apr; 20(4):368-9. PubMed ID: 7788999
    [No Abstract]   [Full Text] [Related]  

  • 9. Thyroid stunning.
    Morris LF; Waxman AD; Braunstein GD
    Thyroid; 2003 Apr; 13(4):333-40. PubMed ID: 12804101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood and bone marrow dosimetry in radioiodine therapy of thyroid cancer.
    Sgouros G
    J Nucl Med; 2005 May; 46(5):899-900; author reply 901. PubMed ID: 15872367
    [No Abstract]   [Full Text] [Related]  

  • 11. Iodine biokinetics and dosimetry in radioiodine therapy of thyroid cancer: procedures and results of a prospective international controlled study of ablation after rhTSH or hormone withdrawal.
    Hänscheid H; Lassmann M; Luster M; Thomas SR; Pacini F; Ceccarelli C; Ladenson PW; Wahl RL; Schlumberger M; Ricard M; Driedger A; Kloos RT; Sherman SI; Haugen BR; Carriere V; Corone C; Reiners C
    J Nucl Med; 2006 Apr; 47(4):648-54. PubMed ID: 16595499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of radioiodine biokinetics following the administration of recombinant human thyroid stimulating hormone and after thyroid hormone withdrawal in thyroid carcinoma.
    Luster M; Sherman SI; Skarulis MC; Reynolds JR; Lassmann M; Hänscheid H; Reiners C
    Eur J Nucl Med Mol Imaging; 2003 Oct; 30(10):1371-7. PubMed ID: 12856155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lithium as an adjuvant in the radioiodine therapy of thyroid cancer].
    Schraube P; Kimmig B; zum Winkel K
    Nuklearmedizin; 1984 Jun; 23(3):151-4. PubMed ID: 6435095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioiodine in thyroid cancer.
    PATERSON R; WARRINGTON HC; GILBERT CW
    Br Med Bull; 1952; 8(2-3):154-7. PubMed ID: 14935223
    [No Abstract]   [Full Text] [Related]  

  • 15. How the availability of recombinant human TSH has changed the management of patients who have thyroid cancer.
    Schlumberger M; Ricard M; De Pouvourville G; Pacini F
    Nat Clin Pract Endocrinol Metab; 2007 Sep; 3(9):641-50. PubMed ID: 17710085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant human thyrotropin-assisted radioiodine therapy for patients with metastatic thyroid cancer who could not elevate endogenous thyrotropin or be withdrawn from thyroxine.
    Robbins RJ; Driedger A; Magner J;
    Thyroid; 2006 Nov; 16(11):1121-30. PubMed ID: 17123339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood and bone marrow dosimetry in radioiodine therapy of differentiated thyroid cancer after stimulation with rhTSH.
    Lassmann M; Hänscheid H; Reiners C; Thomas SR
    J Nucl Med; 2005 May; 46(5):900-1; author reply 901. PubMed ID: 15872369
    [No Abstract]   [Full Text] [Related]  

  • 18. Radioiodine in the treatment of thyroid disease.
    RAWSON RW
    Surg Gynecol Obstet; 1953 Jan; 96(1):118-20. PubMed ID: 13015359
    [No Abstract]   [Full Text] [Related]  

  • 19. Approach to the patient with advanced differentiated thyroid cancer.
    Schlumberger M; Sherman SI
    Eur J Endocrinol; 2012 Jan; 166(1):5-11. PubMed ID: 21890651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review.
    Jarzab B; Handkiewicz-Junak D; Wloch J
    Endocr Relat Cancer; 2005 Dec; 12(4):773-803. PubMed ID: 16322322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.